Mortality and excess life-years lost in patients with schizophrenia under community care: a 5-year follow-up cohort study
- PMID: 36753614
- PMCID: PMC10288468
- DOI: 10.47626/1516-4446-2022-2918
Mortality and excess life-years lost in patients with schizophrenia under community care: a 5-year follow-up cohort study
Abstract
Objective: Mortality rate is a general indicator which can be used to measure care and management of schizophrenia. This cohort study evaluated the standardized mortality ratios (SMRs) of all-cause mortality and life-years lost (LYLs) in patients with schizophrenia under a community care program in China.
Methods: Data were obtained from the National Community Care Program System for Severe Mental Disorders. A total of 99,214 patients diagnosed with schizophrenia were enrolled before December 2014 and followed between 2015 and 2019. A total of 9,483 patients died. Crude mortality rates (CMRs) and SMRs were then stratified by natural vs. unnatural causes, and major groups of death were standardized according to the 2010 National Population SMRs. The corresponding LYLs at birth were also calculated by gender and age.
Results: The SMRs of patients with schizophrenia were significantly elevated during the study period, with an overall SMR of 4.98 (95%CI 2.67-7.32). Neoplasms, cardiovascular diseases, cerebrovascular diseases, external injuries, and poisonings were the most significant causes of death among patients with schizophrenia compared to the general population. The mean LYLs of patients with schizophrenia were 15.28 (95%CI 13.26-17.30). Males with schizophrenia lost 15.82 life-years (95%CI 13.48-18.16), and females lost 14.59 life-years (95%CI 13.12-16.06).
Conclusions: Patients with schizophrenia under community care had a high mortality rate in our study, even though mental health services have been integrated into the general healthcare system in China to narrow treatment gaps in mental health for > 10 years. In terms of mortality outcome indicators, effective and quality mental health services still have a long way to go. The current study demonstrates the potential for improved prevention and treatment of individuals with schizophrenia under community care.
Keywords: Schizophrenia; community; life-years lost; standardized mortality ratio.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
Similar articles
-
Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan.Epidemiol Psychiatr Sci. 2020 Aug 14;29:e156. doi: 10.1017/S2045796020000694. Epidemiol Psychiatr Sci. 2020. PMID: 32792024 Free PMC article.
-
Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.Schizophr Bull. 2021 Mar 16;47(2):474-484. doi: 10.1093/schbul/sbaa137. Schizophr Bull. 2021. PMID: 33009566 Free PMC article.
-
Excess mortality and life-years lost in people diagnosed with depression: A 20-year population-based cohort study of 126,573 depressed individuals followed for 1,139,073 persons-years.Eur Neuropsychopharmacol. 2025 Feb;91:1-8. doi: 10.1016/j.euroneuro.2024.10.009. Epub 2024 Nov 12. Eur Neuropsychopharmacol. 2025. PMID: 39536694
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
-
[Mortality Atlas of the Campania Region. All-cause and cause-specific mortality at municipal level, 2006-2014].Epidemiol Prev. 2020 Jan-Feb;44(1 Suppl 1):1-144. doi: 10.19191/EP20.1.S1.P001.003. Epidemiol Prev. 2020. PMID: 33565290 Review. Italian.
Cited by
-
Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis.EClinicalMedicine. 2023 Oct 31;65:102294. doi: 10.1016/j.eclinm.2023.102294. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37965432 Free PMC article.
-
Does life expectancy vary by disability status in LMICs?: A systematic review and meta-analysis.Afr J Disabil. 2025 Mar 12;14:1514. doi: 10.4102/ajod.v14i0.1514. eCollection 2025. Afr J Disabil. 2025. PMID: 40182075 Free PMC article. Review.
-
Association of relapse with all-cause mortality in adult patients with stable schizophrenia.Int J Neuropsychopharmacol. 2025 May 9;28(5):pyaf018. doi: 10.1093/ijnp/pyaf018. Int J Neuropsychopharmacol. 2025. PMID: 40168136 Free PMC article.
References
-
- Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261. - PubMed
-
- Mavrogiorgou P, Siebers F, Kienast T, Juckel G. [Help-seeking behavior and pathways to care for patients with obsessive-compulsive disorders] Nervenarzt. 2015;86:1130–9. - PubMed
-
- McCutcheon R, Marques TR, Howes OD. Schizophrenia – an overview. JAMA Psychiatry. 2020;77:201–10. - PubMed
-
- Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6:211–24. - PubMed
-
- Liu TL, Zhang L, Pang L, Li N, Chen G, Zheng X. Schizophrenia-related disability in China: prevalence, gender, and geographic location. Psychiatr Serv. 2015;66:249–57. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical